![](/img/cover-not-exists.png)
Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles
Thomas Rabe, Elena Hartschuh, Torsten Wahlstrom, Kornelia Höschen, Simone KönigVolume:
82
Year:
2010
Language:
english
Pages:
366
DOI:
10.1016/j.contraception.2010.04.013
File:
PDF, 290 KB
english, 2010